CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment
J Wen, S Wang, R Guo, D Liu - European Journal of Medicinal Chemistry, 2023 - Elsevier
Abstract ABSTRACT: Colony-Stimulating Factor-1 Receptor (CSF1R) is a receptor tyrosine
kinase that controls the differentiation and maintenance of most tissue-resident …
kinase that controls the differentiation and maintenance of most tissue-resident …
Targeted delivery of pexidartinib to tumor-associated macrophages via legumain-sensitive dual-coating nanoparticles for cancer immunotherapy
DS Liang, WP You, FF Zhu, JH Wang, F Guo… - Colloids and Surfaces B …, 2023 - Elsevier
Tumor-associated macrophage (TAM) is regarded as an appealing cell target for cancer
immunotherapy. However, it remains challenging to selectively eliminate M2-like TAM in …
immunotherapy. However, it remains challenging to selectively eliminate M2-like TAM in …
[HTML][HTML] Colony-Stimulating Factor 1 Receptor: A Novel Target for Cancer Immunotherapy
J Wen, S Luan, D Liu - 2024 - intechopen.com
Abstract The Colony-Stimulating Factor 1 (CSF-1) and its receptor (CSF1R) constitute an
important axis that regulates the phenotype of most tissue-resident macrophages …
important axis that regulates the phenotype of most tissue-resident macrophages …